An ongoing dialogue on HIV/AIDS, infectious diseases,
October 23rd, 2011
TB, Timing of Antiretroviral Therapy, and Being a Lumper Rather Than a Splitter
Three key papers on timing of ART in patients with TB have just been published in the New England Journal of Medicine.
Fortunately, Carlos Del Rio has done a bang-up job summarizing them in Journal Watch AIDS Clinical Care.
And if you’re wondering how we got our title for Carlos’ piece, here’s an e-mail between our Executive Editor to me a few weeks ago:
Hi Paul-
Later this month, NEJM will be publishing three articles on the timing of ART initiation relative to TB treatment. I assume we should cover these?
Cath
To which I responded:
Yep. And they all can be summarized as follows: “TB + low CD4 = start ART sooner rather than later”.
Yes, there are lots more data from these studies than this simple equation, but my response was a reminder that, despite being a thrice-certified ID specialist, I tend to be more of a lumper rather than a splitter — which makes me feel somewhat deficient in our field.
Oh well.
Of course even the less detail-obsessed ID docs like me probably score pretty high on the OCD-meter, so I can take some comfort in that.
Categories: HIV, Infectious Diseases, Patient Care, Research
Tags: antiretroviral therapy, ART, HIV, New England Journal of Medicine, TB, tuberculosis
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
Comments are closed.

Paul E. Sax, MD
Associate Editor
NEJM Clinician
Biography | Disclosures & Summaries
Learn more about HIV and ID Observations.
Search this Blog
Follow HIV and ID Observations Posts via Email
Archives
Most Popular Posts
Sorry. No data so far.
-
From the Blog — Most Recent Articles
- Farewell to This Blog — and Hello to NEJM Voices March 2, 2026
- Some Ruminations on CROI — Still the Best HIV Meeting February 26, 2026
- Two Things Can Be True: The FDA Process Was Inconsistent, and the mRNA Vaccine Data Were Disappointing February 17, 2026
- Sometimes You Just Need to Get Input from a Real Human Being February 12, 2026
- Mystifying Abbreviations — Infectious Diseases Edition February 4, 2026
FROM NEJM — Recent Infectious Disease Articles- Anticompetitive Mergers — Pharmaceutical Buyouts as a Strategy for Maintaining Market Dominance April 18, 2026Consolidation in drug markets could promote availability of innovative treatments. But current antitrust screening is inadequate for detecting anticompetitive behavior, including “killer acquisitions.”
- Risk of Guillain–Barré Syndrome after Laboratory-Confirmed Dengue Infection April 16, 2026In a Brazilian self-controlled case series of 5055 hospitalizations for Guillain–Barré syndrome, laboratory-confirmed dengue was associated with an increased risk of Guillain–Barré syndrome occurring within 42 days.
- Nurse Scientists as Trusted Voices in Health Communication April 16, 2026Despite the erosion of public confidence in science and medicine, nurses remain highly trusted professionals. Integrating nurse scientists into health communication strategies would benefit public health.
- Intraosseous Abscess from Subacute Osteomyelitis April 16, 2026A 16-year-old girl presented with 1 month of ankle pain and 11 days of fever. Radiographs showed an ill-defined, radiolucent distal tibial lesion; on MRI, the lesion was hypointense and surrounded by a hyperintense sclerotic rim.
- The Dismantling of Environmental Protections — A Grave Threat to America’s Health April 16, 2026The Trump administration’s wide-ranging actions to dismantle U.S. environmental regulations will cause long-lasting health harms, disproportionately affecting low-income and other vulnerable groups.
- Anticompetitive Mergers — Pharmaceutical Buyouts as a Strategy for Maintaining Market Dominance April 18, 2026
-
Tag Cloud
- Abacavir AIDS antibiotics antiretroviral therapy ART atazanavir baseball Brush with Greatness CDC C diff COVID-19 CROI darunavir dolutegravir elvitegravir etravirine FDA HCV hepatitis C HIV HIV cure HIV testing ID fellowship ID Learning Unit Infectious Diseases influenza Link-o-Rama lyme disease medical education MRSA PEP PrEP prevention primary care raltegravir Really Rapid Review resistance Retrovirus Conference rilpivirine sofosbuvir TDF/FTC tenofovir Thanksgiving vaccines zoster
